Carani Sanjeevi
Director/Board Member at Allarity Therapeutics Europe ApS
Network origin in Carani Sanjeevi first degree
Entity | Entity type | Industry | |
---|---|---|---|
Karolinska Institutet
121
| College/University | Other Consumer Services | 121 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
13
| Private Company | Pharmaceuticals: Major | 13 |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Carani Sanjeevi via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Royal Swedish Academy of Sciences
Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Sciences provides research and development services on sciences. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
OREXO AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Copenhagen Business School | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Aarhus | College/University | Doctorate Degree Graduate Degree | |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
University of Stockholm | College/University | Doctorate Degree Director/Board Member Graduate Degree | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Founder Founder Corporate Officer/Principal | |
University of Lund | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Gothenburg | College/University | Doctorate Degree Corporate Officer/Principal | |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | President President | |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Investment Managers | Chairman Analyst-Equity | |
BIOARCTIC AB | Pharmaceuticals: Major | Founder Director/Board Member | |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member Director/Board Member | |
NEOS AB | Medical Specialties | Director/Board Member Founder Founder | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Corporate Officer/Principal Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
KANCERA AB | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
Contera Pharma ApS
Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chairman Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member | |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
INHALATION SCIENCES SWEDEN AB | Medical Specialties | Director/Board Member Founder | |
CALMARK SWEDEN AB | Medical Specialties | Director/Board Member Director/Board Member | |
VALNEVA | Biotechnology | Director/Board Member Director/Board Member | |
PEPTONIC MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Founder | |
Medical Prognosis Institute, Inc. | Chairman Director/Board Member Chief Executive Officer | ||
KARESSA PHARMA HOLDING AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Disruptive Materials AB
Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
INITIATOR PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder Director/Board Member | |
Spatial Transcriptomics AB
Spatial Transcriptomics AB Miscellaneous Commercial ServicesCommercial Services Spatial Transcriptomics AB develops technology for RNA sequencing. Its system bridges microscopy and RNA sequencing to generate complete transcriptome data from a single intact tissue sample, and utilizes standard instrumentation for sequencing. The firm's products include ST Tissue Optimization Slide and ST Library Preparation Slide. The company was founded by Jonas Christopher Frisén, Joakim Lundeberg, and Patrik Ståhl and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Founder | |
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
ALLARITY THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Executive Officer Director/Board Member | |
BIOSERGEN AB | Biotechnology | Director/Board Member Director of Finance/CFO | |
BACTIGUARD HOLDING AB | Medical Specialties | Director/Board Member Director/Board Member |
Statistics
International
Sweden | 37 |
Denmark | 7 |
United States | 5 |
United Kingdom | 2 |
Austria | 2 |
Sectoral
Health Technology | 32 |
Consumer Services | 7 |
Commercial Services | 6 |
Finance | 5 |
Health Services | 3 |
Operational
Director/Board Member | 406 |
Corporate Officer/Principal | 241 |
Chairman | 104 |
Independent Dir/Board Member | 77 |
Founder | 71 |
Most connected contacts
- Stock Market
- Insiders
- Carani Sanjeevi
- Company connections